Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Cholecystitis

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcomes of radiotherapy of hepatocellular carcinoma: a retrospective analysis.

Radiation oncology (London, England)·2026

Same author

Total Neoadjuvant Therapy with FOLFOX Followed by Short-Course Radiation in Locally Advanced Rectal Cancer-An Alternative Approach Evaluated in a Single-Center Clinical Trial.

Journal of clinical medicine·2026

Same author

Phase 2 trial of exercise and low-dose ibuprofen for cancer-related cognitive impairment in patients receiving chemotherapy.

Cancer·2026

Same author

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.

Hepatology (Baltimore, Md.)·2026

Same author

Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapy.

Cell reports. Medicine·2025

Same author

Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation.

Nature communications·2025

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Current management of gallbladder carcinoma.

Andrew X Zhu¹, Theodore S Hong, Aram F Hezel

¹Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts 02114, USA. azhu@partners.org

|February 12, 2010

Summary

Gallbladder cancer (GBC) is aggressive, with surgery offering the only cure but rarely being an option. Chemotherapy shows promise for advanced GBC, but new treatments are needed.

More Related Videos

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

Related Experiment Videos

Last Updated: Jun 16, 2026

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

Area of Science:

Oncology
Gastroenterology

Background:

Gallbladder cancer (GBC) is the most common and aggressive biliary tract cancer (BTC).
Complete surgical resection is the only curative option, but only 10% of patients are eligible due to late diagnosis.
High recurrence rates after surgery and lack of effective adjuvant treatments contribute to poor outcomes.

Purpose of the Study:

To review the current management strategies for gallbladder cancer.
To discuss key issues and recent advancements in GBC treatment.
To highlight the need for further research in adjuvant therapies and targeted agents.

Main Methods:

Literature review of current GBC management.
Analysis of recent clinical trial data, including phase III studies.
Discussion of chemotherapy regimens and molecularly targeted agents.

Main Results:

Gemcitabine plus cisplatin demonstrated improved overall survival compared to gemcitabine alone in advanced BTC.
Limited randomized phase III data exists for GBC adjuvant treatment.
Molecularly targeted agents are under investigation for GBC treatment.

Conclusions:

Surgical resection remains the cornerstone for curable GBC, despite high recurrence rates.
Chemotherapy combinations show potential for advanced GBC, but further validation is required.
Development of novel adjuvant and targeted therapies is crucial for improving GBC patient outcomes.